Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 10 of 10 for “"Rb loss"”.
-
Targeting Vulnerabilities in RB-deficient Breast Cancer
… needed. Most TNBC cases have mutations in TP53. RB-loss is also seen in ~30% of TNBCs and is associated with metastasis. As RB-loss is not directly druggable, identifying downstream pathways may expose vulnerabilities that are amenable to therapeutic interventions. Employing murine models of TNBC …
-
Role of retinoblastoma protein in the development of liver cancer
… with a diverse aetiology. Dysregulation of the Rb pathway can occur in as high as 92% of liver cancers implicating Rb as an important factor in the progression of the disease. The impact Rb loss has on the development of liver cancer was determined using an in vitro system, with Cre-lox …
-
Differential Roles of AKT Isoforms in Metastatic Prostate Cancer
… AKT yet dramatically different phenotypes. The loss of PTEN function, one of the most frequent mutations in CaP, is presumed to drive disease progression through activation of PI3K/AKT signaling. However, two transgenic mouse CaP models that genocopy changes found in human CaP, Pten/Rb-loss and …
-
Genetic and Pharmacological Approaches to Understand the Multitude Functions of RB in Triple Negative Breast Cancer
The retinoblastoma (RB) tumor suppressor protein is a key regulator of cell cycle progression that is frequently genetically or functionally inactivated in triple-negative breast cancer (TNBC). While CDK4/6 inhibitors (CDK4/6i) can activate RB and suppress proliferation, their therapeutic efficacy …
-
Targeting Retinoblastoma tumour suppressor deficiency in Leiomyosarcoma
… in <em>TP53</em> and Retinoblastoma (<em>RB1</em>) genes in LMS suggests disruptions in normal cell cycle pathways controlling checkpoints and DNA repair mechanisms. In this study, we aimed to identify drugs that exhibit a synthetic lethality effect with <em>RB1</em> gene mutations in …
-
Targeting Cyclin Dependent Kinases 4/6 Activity in Pancreatic Ductal Adenocarcinoma
… to CDK4/6 inhibition. Prior to this study, RB loss was the only mechanism known to circumvent CDK4/6 inhibition. However, herein, we uncovered that CDK4/6 inhibition can lead to aberrant Cyclin E expression, which can compensate for CDK4/6 activity loss and maintain RB in a …
-
Investigating biomarkers of response to CDK4/6 inhibition in combination with anti-estrogen therapy in breast cancer cell lines
… blot analysis identified p16 overexpression and Rb loss as markers of resistance to palbociclib. RPPA analyses identified an additional thirteen differentially expressed proteins associated with palbociclib resistance. I also identified twelve proteomic biomarkers of resistance to the combination …
-
Genetic Analysis of Triple-Negative Breast Cancer and Pineoblastoma
… young women. The tumor suppressor genes TP53 and RB1 are commonly lost together in a subset of TNBC with exceedingly poor prognosis. The identification of oncogenic drivers that cooperate with p53/Rb-loss in TNBC may uncover novel therapeutic modalities. Here, I employed sleeping beauty (SB) …
-
Preservation of Sedimentary Rubidium Isotopic Signatures in Subduction Zones: Insights From the Schistes Lustrés HP-UHP Metasediments, Western Alps
… fluid-mobile elements such as rubidium (Rb), are lost into fluids during metamorphic dehydration, and how much is transported to sub-arc depths where arc magmas are generated. Rubidium in subducting sediments is mainly hosted in detrital phases (e.g., clay and mica), but is variable …
-
Understanding and Targeting Fatty Acid-CoA Ligase ACSL4 in Advanced Human Prostate Cancer
… lab and others highlights the pivotal role of RB1 loss in driving lineage plasticity, metastasis, and lethality of prostate tumors. One downstream target of RB1 loss/E2F activation is acyl-CoA synthetase long-chain family member 4 (ACSL4), a fatty acid ligase crucial for the utilization of …